Puma Biotechnology News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.10.18	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
02.10.18	Puma Biotechnology’s Licensing Partner CANbridge Pharmaceutical Submits New Drug Application for NERLYNX® (neratinib) in China (Businesswire)
20.09.18	Puma Biotechnology to Present at Cantor Global Healthcare Conference (Businesswire)
06.09.18	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
04.09.18	EC Grants Marketing Authorisation For Puma Biotechnology's NERLYNX (RTTNews)
04.09.18	European Commission Grants Marketing Authorisation for Puma Biotechnology’s NERLYNX® (neratinib) for Extended Adjuvant Treatment of Hormone Receptor Positive HER2-Positive Early Stage Breast Cancer (Businesswire)
10.08.18	SPRO To Report Data In Q3, ITRM Takes Steady And SURE Steps, PBYI On Watch (RTTNews)
09.08.18	Puma Biotechnology Reports Second Quarter 2018 Financial Results (Businesswire)
31.07.18	Puma Biotechnology Files New Drug Submission for NERLYNX® in Canada (Businesswire)
26.07.18	Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results (Businesswire)
17.07.18	Puma Biotechnology and Strata Oncology Announce Collaboration to Accelerate Enrollment in Neratinib HER2 Mutation Basket Study (SUMMIT Trial) (Businesswire)
29.06.18	Puma Biotechnology Receives Positive CHMP Opinion Recommending Approval of NERLYNX® for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer (Businesswire)
27.06.18	SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz (RTTNews)
26.06.18	Puma Biotechnology Announces Results of CHMP Reexamination of MAA for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer (Businesswire)
18.06.18	Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies (PR Newswire)
30.05.18	Puma Biotechnology to Present at Jefferies Global Healthcare Conference (Businesswire)
09.05.18	Puma Biotechnology Reports First Quarter 2018 Financial Results (Businesswire)
08.05.18	Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2018 (Businesswire)
01.05.18	Don't Let the Check Engine Light Turn You Off From Making Needed Repairs (PR Newswire)
25.04.18	Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results (Businesswire)
03.04.18	Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America (Businesswire)
02.04.18	NCCN Guidelines for Central Nervous System Cancers Include NERLYNX® (neratinib) in Combination With Capecitabine or Paclitaxel as Treatment Options for Patients With Breast Cancer Brain Metastases (Businesswire)
06.03.18	Puma Biotechnology to Present at Cowen’s Annual Healthcare Conference (Businesswire)
01.03.18	Puma Biotechnology Reports Fourth Quarter and Full Year 2017 Financial Results (Businesswire)
23.02.18	Puma Biotechnology Receives Results of CHMP Formal Decision for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer (Businesswire)
15.02.18	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results (Businesswire)
07.02.18	Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference (Businesswire)
01.02.18	Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Greater China (Businesswire)
31.01.18	Puma Biotechnology Announces Publication of Results from Phase II SUMMIT ‘Basket’ Trial Evaluating Neratinib in HER2 and HER3 Mutant Cancers (Businesswire)
30.01.18	Puma Biotechnology and Medison Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Israel (Businesswire)
29.01.18	Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) (Businesswire)
24.01.18	AMRN Looks Forward To Big Event, PBYI Plunges After-hours, SPARC Lights Up CERS (RTTNews)
23.01.18	Puma Biotechnology Announces Results of CHMP Oral Explanation for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer (Businesswire)
14.12.17	Puma Biotechnology Added to NASDAQ Biotechnology Index (Businesswire)
13.12.17	Puma Biotechnology Announces Meeting of Scientific Advisory Group on Oncology in Europe to Review Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer (Businesswire)
12.12.17	Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer (Businesswire)
11.12.17	Puma Biotechnology Announces Positive Outcome of European Opposition Proceedings (Businesswire)
22.11.17	New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal (PR Newswire)
22.11.17	Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Australia, New Zealand and South East Asia (Businesswire)
14.11.17	Puma Biotechnology’s 5-Year Analysis of Phase III ExteNET Study Published Online in The Lancet Oncology (Businesswire)
09.11.17	Puma Biotechnology Reports Third Quarter 2017 Financial Results (Businesswire)
08.11.17	Puma Biotechnology to Present at Stifel Healthcare Conference (Businesswire)
02.11.17	Puma Biotechnology Secures $100 Million Term Loan from Silicon Valley Bank and Oxford Finance (Businesswire)
31.10.17	Puma Biotechnology to Present at Credit Suisse Healthcare Conference (Businesswire)
26.10.17	Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results (Businesswire)
14.09.17	Stocks Under Scanner in the Biotech Space -- Puma Biotech, Regeneron Pharma, Sarepta Therapeutics, and Seattle Genetics (PR Newswire)
08.09.17	Puma Biotechnology Presents 5-Year Analysis of Phase III ExteNET Trial in Extended Adjuvant HER2-Positive Breast Cancer at ESMO 2017 Congress (Businesswire)
07.09.17	Consumer Watchdog Praises Tech Giant Oracle Support for Amending Internet Law to Stop Sex Trafficking; Challenges Google, Facebook, Twitter, Amazon and Yelp! to Act in Public's Interest (PR Newswire)
31.08.17	Puma Biotechnology Announces Publication of Abstracts for ESMO 2017 (Businesswire)
30.08.17	ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Puma Biotechnology Inc

Aktien Top/Flop

Meistgelesene Nachrichten